Pfizer kicks off 50th Anniversary Celebrations in Ireland

Pfizer kicks off 50th Anniversary Celebrations in Ireland

Company global head of manufacturing starts week-long tour of Irish operations

Pfizer kicks off 50th Anniversary Celebrations in Ireland

Media Release

Tuesday 14h May 2019

 

Pfizer kicks off 50th Anniversary Celebrations in Ireland

 

Company global head of manufacturing starts week-long tour of Irish operations

 

 

May 14th, 2019, Ringaskiddy, Co. Cork.  As part of the celebrations of the 50th Anniversary of Pfizer in Ireland, Mr. Mike McDermott, President, Pfizer Global Supply has visited Pfizer’s manufacturing sites at Little Island and Ringaskiddy, Co. Cork, travelling onward to the company’s Newbridge and Grange Castle manufacturing sites later this week.

 

“I am delighted to be in Ireland - the decision to establish a manufacturing facility in Ireland fifty years ago has benefited Pfizer and Ireland,” said McDermott. Outside of the U.S., our Irish operations are substantial and we are proud of our Irish workforce who play an important role in getting innovative medicines to patients in over 100 countries around the world.  We began in Ringaskiddy manufacturing citric acid – now we manufacture complex medicines for cancer, infectious disease, inflammation and stroke prevention from our Irish sites. Pfizer’s priority is researching and developing medicines and vaccines that will transform patient’s lives.  In addition to the medicines manufactured today, we a strong pipeline of potential new treatments, with 97 projects currently at different stages of the clinical trial journey.”

 

“Pfizer was one of the first multinationals to respond to government policy seeking to attract investment in Ireland and the government and IDA have been very supportive of the company over the last 50 years,” said Dr. Paul Duffy, Vice President, Pfizer Global Supply.  “Colleagues have played an enormous role in helping grow the Irish operations - from an initial 16 colleagues in 1969, the Pfizer team in Ireland now numbers over 3,700 people and the company contributes over €2 billion in economic output to the Irish economy annually. This is an exciting time for the company and we are currently recruiting for a diverse range of roles from manufacturing to accounting in our Irish operations,” said Duffy. 

 

Pfizer Ireland is currently recruiting for a number of roles across the Irish operations, please visit www.Pfizer.com/careers for more information or to apply.

 

As part of the 50th Anniversary Celebrations, a team of Pfizer colleagues have curated an exhibition detailing the history of Pfizer in Ireland, the significant milestones during this time and the people behind the company. The Exhibition will be open to the public at Cork City Library from 27 May - 14 June.

 

Pfizer is one of Ireland's largest pharmaceutical sector investors and employers. One of the first pharmaceutical companies to locate in Ireland (1969), Pfizer has over 3,700 colleagues across 6 locations based in Cork, Dublin, and Kildare.  Total capital investment by the company in Ireland exceeds $8billion.  Pfizer's business interests in Ireland are diverse and include manufacturing, shared (financial) services, scientific research and development (R&D) and commercial operations.  Part of Pfizer's Worldwide Research & Development (WR&D) is based in Ireland - the Global Biotherapeutics Technology group at Grange Castle was established in 2006 and is part of a world-leading protein drug discovery unit within Pfizer Worldwide R&D.

For more information, please contact:

Natalie Tennyson / Karen O’Keeffe, Pfizer Corporate Affairs

E: [email protected] / [email protected]

T: 083 1271277 / 086 8574291

Published: .


« Return to the News section